MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0000061
Advy Biosciences Private Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹194.68 Cr
▲ 19% YoY
Net profit · FY 2025
₹20.03 Cr
Net margin 10.3%
EBITDA · FY 2025
₹38.62 Cr
EBITDA margin 19.8%
Authorised capital
₹4.5 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Open charges
₹125.56 Cr
Satisfied ₹12.98 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
262
Provident fund records
About Advy Biosciences Private Limited
Data last updated:
Advy Biosciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 22 October 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24297MH2010PTC209352. Its GSTIN is 27AAICA9203E1ZV (Maharashtra).
The company has an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹4 Cr. It was formerly known as Advy Chemical Private Limited. It is led by directors including Siddharth Bharat Daftary (Managing Director) and Rahul Purwar.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 17th Floor Hoechst House Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹194.68 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹20.03 Cr (net margin 10.3%) and EBITDA of ₹38.62 Cr (EBITDA margin 19.8%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 37% over five years.
The company has about 262 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Advy Chemical. As per MCA filings, the company has open charges of ₹125.56 Cr and satisfied charges of ₹12.98 Cr on record. Court records list 10 cases involving the company, including 9 filed by the company and 1 filed against it; 1 case is pending. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹3 Cr; the latest was in August 2024. Its 7 peer companies in the Chemicals industry (Biosciences, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Dai-Ichi Karkaria Limited with revenue of ₹198.07 Cr.
Advy Biosciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0000061). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website advychemical.com.
Company details
CIN U24297MH2010PTC209352
Registration Number 209352
Incorporation Date 22 October 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 22 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0000061
Key People
Siddharth Bharat Daftary Managing Director Rahul Purwar Director Raj Nautam Parekh Director Recognitions & Rankings of Advy Biosciences
Contact details
Advy Biosciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is advychemical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address17th Floor Hoechst House Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Advy Biosciences Private Limited, buy the company report.
Comprehensive company report
Advy Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Advy Biosciences operates one associated brand: Advy Chemical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops antigen,polyclonal antibodies and In-Vitro diagnostic tests for infectious diseases . | advychemical.com |
Business activity
The main business activity of Advy Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Advy Biosciences Private Limited, buy the company report.
Financials of Advy Biosciences Private Limited
FY 2025 filings availableAdvy Biosciences Private Limited reported revenue of ₹194.68 Cr (up 19% YoY) for FY 2025.
Revenue · FY 2025
₹194.68 Cr ▲ 19%
Net profit · FY 2025
₹20.03 Cr margin 10.3%
EBITDA · FY 2025
₹38.62 Cr margin 19.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 8%
5 years · compounded
▲ 37%
EBITDA CAGR growth
1 year
▲ 54%
3 years · compounded
▼ 9%
5 years · compounded
▲ 98%
Revenue has grown at a compounded annual rate (CAGR) of 37% over five years, including 19% growth in the latest year. EBITDA rose 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38.62 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20.03 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.8% | ||||
| Net Profit Margin | 10.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Advy Biosciences Private Limited, buy the company report.
Board of directors of Advy Biosciences Private Limited
Advy Biosciences has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Purwar | Director | 24 Jun 2022 | 4 Years 4 Months | Current |
| Raj Nautam Parekh Also directs: Morpheus Life Sciences Private Limited | Director | 24 Mar 2015 | 11 Years 7 Months | Current |
| Siddharth Bharat Daftary Also directs: Risam Pure LLP, BVD Healthcare Venture LLP, Hitech Laboratories Private Limited and 5 more | Managing Director | 22 Oct 2010 | 16 Years 0 Months | Current |
| Ajeet Singh Karan Also directs: Ace Findistria India Private Limited | Director | 22 May 2025 | 1 Years 5 Months | Current |
Peer comparison
Advy Biosciences Private Limited is compared with the 7 companies closest to it by revenue in the Chemicals industry (Biosciences, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dai-Ichi Karkaria Limited | ₹198.07 Cr (FY 2016) | 5.0% | Mumbai, Maharashtra, India | |||
| Agarwal Aromas Private Limited | ₹196.99 Cr (FY 2025) | 1.0% | Uttar Pradesh, India | |||
| Daffodil Pharmachem Private Limited | ₹196.29 Cr (FY 2025) | -27.0% | Ahmedabad, Gujarat, India | |||
| Advy Biosciences Private Limitedthis company | ₹194.68 Cr (FY 2025) | ₹20.03 Cr | 10.3% | 19.0% | 262 | Mumbai, Maharashtra, India |
| Sarna Chemicals Private Limited | ₹193.99 Cr (FY 2025) | 32.0% | Vapi, Gujarat, India | |||
| Vasant Chemicals Private Ltd. | ₹191.96 Cr (FY 2025) | 61.0% | Hyderabad, Telangana, India | |||
| Indo Borax & Chemicals Limited | ₹190.85 Cr (FY 2025) | -6.0% | Mumbai, Maharashtra, India | |||
| Narmada Gelatines Limited | ₹190.57 Cr (FY 2025) | 4.0% | Jabalpur, Madhya Pradesh, India |
To see the full peer comparison of Advy Biosciences Private Limited, buy the company report.
Auditor
Advy Biosciences Private Limited is audited by V. V. Rane & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V. V. Rane & Co | FY 2023 | 128871W |
Shareholding
The shareholding of Advy Biosciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Advy Biosciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹125.56 Cr
Satisfied charges
₹12.98 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Aug 2025 | 101150486 | Axis Bank Limited | ₹25 Cr | Open | |
| 20 Jun 2025 | 101124629 | Others | ₹20 Cr | Open | |
| 31 Jan 2025 | 101061024 | Axis Bank Limited | ₹5 Cr | Open | |
| 23 Dec 2021 | 100526150 | The Hongkong and Shanghai Banking Corporation Limited | ₹10 Cr | Open | |
| 31 Jul 2020 | 100371570 | Axis Bank Limited | ₹3.48 Cr | Open |
To see the full charge records of Advy Biosciences Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Advy Biosciences Private Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹3 Cr; the latest was in August 2024.
Total deals
4
Secondary share transfers
3
Funding round
1
Disclosed funding
₹3 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| May 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Jan 2012 | Funding round | ₹3 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Advy Biosciences Private Limited has 10 court cases on record: 9 filed by Advy Biosciences, 1 filed against it. 1 case is pending and 9 are disposed.
Total cases
10
Filed by the company
9
Filed against the company
1
Pending
1
Disposed
9
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 0 | 0 |
| District courts | 3 | 1 | 1 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Inspector Under Maharashtra Private Security Guards Through Priyanka Nikam | Pending |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against State of Maharashtra and 5 Ors and 6 others | Disposed |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against The State of Maharashtra and 5 Ors and 5 others | Disposed |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against State of Maharashtra and 2 Ors. and 2 others | Disposed |
| High Court of Delhi | Appeal | Filed by the company against M/S Aenika Health Care Ltd & Ors | Disposed |
To see the full case history of Advy Biosciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Advy Biosciences Private Limited was last rated by Crisil on 29 Jul 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 29 Jul 2020 |
To see the full credit ratings and regulatory alerts of Advy Biosciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Advy Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Advy Biosciences Private Limited has a workforce of 262 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
262
Active EPFO establishments
1
Employee growth
-8.07%
GST
Advy Biosciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICA9203E1ZV | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Advy Biosciences Private Limited, buy the company report.
Recent activity
Advy Biosciences Private Limited has 11 board changes on record since 2010: 4 appointments and 7 cessations. The latest: Siddharth Bharat Daftary ceased to be Director on 15 Oct 2025.
Ceased
Siddharth Bharat Daftary ceased to be Director.
AGM
Advy Biosciences Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records.
Ceased
Ajeet Singh Karan ceased to be Additional Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 25.00 Cr with Charge ID 101150486 was registered on 05 Aug 2025.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101124629 was registered on 20 Jun 2025.
Appointed
Ajeet Singh Karan was appointed as Director.
Filing
Advy Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Axis Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101061024 was registered on 31 Jan 2025.
Ceased
Bharat Vinod Daftary ceased to be Director.
Ceased
Nitin Jagannath Deshmukh ceased to be Additional Director.
Ceased
Rahul Purwar ceased to be Additional Director.
Appointed
Rahul Purwar was appointed as Director.
15 earlier events are in the company report.
Frequently asked questions
Advy Biosciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 22 October 2010 (16+ years old) and is registered under CIN U24297MH2010PTC209352.
Advy Biosciences has 4 current directors:
- Siddharth Bharat Daftary - Managing Director
- Rahul Purwar - Director
- Raj Nautam Parekh - Director
- Ajeet Singh Karan - Director
The latest financial statements of Advy Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Advy Biosciences is 27AAICA9203E1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Advy Biosciences is U24297MH2010PTC209352. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Advy Biosciences has 10 court cases on record: 9 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Advy Biosciences was incorporated on 22 October 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Advy Biosciences has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹3 Cr; the latest was in August 2024.
The peers of Advy Biosciences by revenue are Dai-Ichi Karkaria Limited, Agarwal Aromas Private Limited, Daffodil Pharmachem Private Limited, Sarna Chemicals Private Limited, Vasant Chemicals Private Ltd. and 2 more, all in the Chemicals industry (Biosciences, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Siddharth Bharat Daftary ceased to be Director on 15 Oct 2025. Ajeet Singh Karan ceased to be Additional Director on 21 Sep 2025. Ajeet Singh Karan was appointed as Director on 22 May 2025. Advy Biosciences has 11 board changes on record in total.
Yes, Advy Biosciences is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0000061).